Viking Therapeutics, Inc. (VKTX): auditor change — Viking Therapeutics appoints CBIZ as independent auditor after Marcum resignation

Viking Therapeutics, Inc.

Marcum resigned April 18, 2025, after CBIZ acquired its attest business.
Audit committee appointed CBIZ as auditor for FY2025 on April 22, 2025.
No disagreements or reportable events with Marcum in FY2023 or FY2024.
Company will file revised proxy for May 20, 2025 annual meeting to reflect CBIZ in Proposal 2.

item 4.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

Marcum LLP resigned as auditor of Viking Therapeutics, Inc..

Action: resignation
Auditor: Marcum LLP

Exact text from the filing

on April 18, 2025, as a result of the acquisition, Marcum resigned as the independent registered public accounting firm of Viking Therapeutics, Inc.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

Viking Therapeutics, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

(a) Resignation of Independent Registered Public Accounting Firm On November 1, 2024, CBIZ CPAs P.C. (“CBIZ”) acquired the attest business of Marcum LLP (“Marcum”), and substantially all of the partners and staff that provided attestation services with Marcum joined CBIZ in connection with the acquisition. Accordingly, on April 18, 2025, as a result of the acquisition, Marcum resigned as the independent registered public accounting firm of Viking Therapeutics, Inc. (the “Company”) and, on April 22, 2025, the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) approved the appointment of CBIZ as the Company’s independent registered public accounting firm. The reports of Marcum on the Company’s consolidated financial statements for the years ended December 31, 2024, and December 31, 2023, did not contain an adverse opinion or a disclaimer of opinion, and were not qu

View on SEC.gov

Browse all auditor changes →

Viking Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-057323

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.